Skip to main content

Advertisement

SpringerLink
Log in

The Challenges of Prevention, Diagnosis and Treatment of Ischemic Heart Disease in Women

  • ORIGINAL ARTICLE
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Increasing evidence suggests that there are significant differences in the presentation, diagnosis and treatment of ischemic heart disease in women compared to men. Women often present with atypical symptoms, and this, in association with a consistent underestimation of their risk for ischemic heart disease, leads to underdiagnosis and undertreatment in women. Cardiovascular risk factors unique to women have only recently been recognized, and moreover, traditional risk factors have recently been shown to have greater impacts on women. Consequently, women suffer more disability and poorer clinical outcomes, with higher cardiovascular morbidity and mortality. These discrepancies may in part be secondary to the higher prevalence of nonobstructive coronary artery disease in women with persistent chest pain symptoms as compared to men when evaluated invasively. Focused diagnostic and therapeutic strategies unique to women are thus needed, but unfortunately, such sex-specific guidelines do not yet exist, largely due to lack of awareness, both on the part of providers and patients, as well as a paucity of evidence-based research specific to women. Although underutilized in women, diagnostic modalities, including functional and anatomic cardiac tests as well as physiologic assessments of endothelial and microvascular function, are useful for establishing the diagnosis and prognosis of suspected ischemic heart disease in women. This review discusses the current challenges of prevention, diagnosis and treatment of ischemic heart disease in women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics--2015 update: a report from the american heart association. Circulation. 2015;131:e29–e322.

    Article  PubMed  Google Scholar 

  2. Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, et al. Insights from the nhlbi-sponsored women’s ischemia syndrome evaluation (wise) study: Part i: Gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol. 2006;47:S4–S20.

    Article  PubMed  Google Scholar 

  3. Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol. 2009;54:1561–75.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Kim ES, Carrigan TP, Menon V. Enrollment of women in national heart, lung, and blood institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion. J Am Coll Cardiol. 2008;52:672–3.

    Article  PubMed  Google Scholar 

  5. Bucholz EM, Butala NM, Rathore SS, Dreyer RP, Lansky AJ, Krumholz HM. Sex differences in long-term mortality after myocardial infarction: a systematic review. Circulation. 2014;130:757–67.

    Article  PubMed  Google Scholar 

  6. Wenger NK. Women and coronary heart disease: a century after Herrick: understudied, underdiagnosed, and undertreated. Circulation. 2012;126:604–11.

    Article  PubMed  Google Scholar 

  7. Towfighi A, Zheng L, Ovbiagele B. Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med. 2009;169:1762–6.

    Article  PubMed  Google Scholar 

  8. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the nurses’ health study. N Engl J Med. 1991;325:756–62.

    Article  CAS  PubMed  Google Scholar 

  9. Campisi R. Noninvasive assessment of coronary microvascular function in women at risk for ischaemic heart disease. Int J Clin Pract. 2008;62:300–7.

    Article  CAS  PubMed  Google Scholar 

  10. Mack M, Gopal A. Epidemiology, traditional and novel risk factors in coronary artery disease. Cardiol Clin. 2014;32:323–32.

    Article  PubMed  Google Scholar 

  11. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Executive summary: heart disease and stroke statistics--2010 update: a report from the american heart association. Circulation. 2010;121:948.

    Article  PubMed  Google Scholar 

  12. Feinstein M, Ning H, Kang J, Bertoni A, Carnethon M, Lloyd-Jones DM. Racial differences in risks for first cardiovascular events and noncardiovascular death: the atherosclerosis risk in communities study, the cardiovascular health study, and the multi-ethnic study of atherosclerosis. Circulation. 2012;126:50–9.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Ford ES, Capewell S. Coronary heart disease mortality among young adults in the us from 1980 through 2002: Concealed leveling of mortality rates. J Am Coll Cardiol. 2007;50:2128–32.

    Article  PubMed  Google Scholar 

  14. Dreyer RP, Smolderen KG, Strait KM, Beltrame JF, Lichtman JH, Lorenze NP, et al. Gender differences in pre-event health status of young patients with acute myocardial infarction: a virgo study analysis. Eur Heart J Acute Cardiovasc Care. in press.

  15. Zuchi C, Tritto I, Ambrosio G. Angina pectoris in women: focus on microvascular disease. Int J Cardiol. 2013;163:132–40.

    Article  PubMed  Google Scholar 

  16. Hemingway H, Langenberg C, Damant J, Frost C, Pyörälä K, Barrett-Connor E. Prevalence of angina in women versus men a systematic review and meta-analysis of international variations across 31 countries. Circulation. 2008;117:1526–36.

    Article  PubMed  Google Scholar 

  17. Mieres JH, Heller GV, Hendel RC, Gulati M, Boden WE, Katten D, et al. Signs and symptoms of suspected myocardial ischemia in women: results from the what is the optimal method for ischemia evaluation in women? Trial J Womens Health. 2011;20:1261–8.

    Article  Google Scholar 

  18. Eastwood J-A, Johnson BD, Rutledge T, Bittner V, Whittaker KS, Krantz DS, et al. Anginal symptoms, coronary artery disease, and adverse outcomes in black and white women: the nhlbi-sponsored women’s ischemia syndrome evaluation (wise) study. J Womens Health. 2013;22:724–32.

    Article  Google Scholar 

  19. Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the women’s ischemia syndrome evaluation study and the st james women take heart project. Arch Intern Med. 2009;169:843–50.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Tamis-Holland JE, Lu J, Korytkowski M, Magee M, Rogers WJ, Lopes N, et al. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the bari 2d trial (bypass angioplasty revascularization investigation 2 diabetes). J Am Coll Cardiol. 2013;61:1767–76.

    Article  PubMed  Google Scholar 

  21. Vaccarino V. Ischemic heart disease in women many questions, few facts. Circ Cardiovasc Qual Outcomes. 2010;3:111–5.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Sharaf BL, Pepine CJ, Kerensky RA, Reis SE, Reichek N, Rogers WJ, et al. Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the nhlbi-sponsored women’s ischemia syndrome evaluation [wise] study angiographic core laboratory). Am J Cardiol. 2001;87:937–41.

    Article  CAS  PubMed  Google Scholar 

  23. Shaw LJ, Merz CN, Pepine CJ, Reis SE, Bittner V, Kip KE, et al. The economic burden of angina in women with suspected ischemic heart disease: results from the national institutes of health--national heart, lung, and blood institute--sponsored women’s ischemia syndrome evaluation. Circulation. 2006;114:894–904.

    Article  PubMed  Google Scholar 

  24. Shaw LJ, Shaw RE, Merz CNB, Brindis RG, Klein LW, Nallamothu B, et al. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the american college of cardiology–national cardiovascular data registry. Circulation. 2008;117:1787–801.

    Article  PubMed  Google Scholar 

  25. Maynard C, Fisher L, Passamani E, Pullum T. Blacks in the coronary artery surgery study: risk factors and coronary artery disease. Circulation. 1986;74:64–71.

    Article  CAS  PubMed  Google Scholar 

  26. Gulati M, Shaw LJ, Merz B, Noel C. Myocardial ischemia in women: lessons from the nhlbi wise study. Clin Cardiol. 2012;35:141–8.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Bransford TL, Ofili E. The paradox of coronary heart disease in african-american women. J Natl Med Assoc. 2000;92:327.

    PubMed Central  CAS  PubMed  Google Scholar 

  28. Mensah GA, Brown DW. An overview of cardiovascular disease burden in the united states. Health Aff. 2007;26:38–48.

    Article  Google Scholar 

  29. Mosca L, Hammond G, Mochari-Greenberger H, Towfighi A, Albert MA. Fifteen-year trends in awareness of heart disease in women results of a 2012 american heart association national survey. Circulation. 2013;127:1254–63.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Papakonstantinou NA, Stamou MI, Baikoussis NG, Goudevenos J, Apostolakis E. Sex differentiation with regard to coronary artery disease. J Cardiol. 2013;62:4–11.

    Article  PubMed  Google Scholar 

  31. Gupta A, Wang Y, Spertus JA, Geda M, Lorenze N, Nkonde-Price C, et al. Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010. J Am Coll Cardiol. 2014;64:337–45.

    Article  PubMed Central  PubMed  Google Scholar 

  32. van Loo HM, van den Heuvel ER, Schoevers RA, Anselmino M, Carney RM, Denollet J, et al. Sex dependent risk factors for mortality after myocardial infarction: Individual patient data meta-analysis. BMC Med. 2014;12:242.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Vaccarino V, Horwitz RI, Meehan TP, Petrillo MK, Radford MJ, Krumholz HM. Sex differences in mortality after myocardial infarction: evidence for a sex-age interaction. Arch Intern Med. 1998;158:2054–62.

    Article  CAS  PubMed  Google Scholar 

  34. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. N Engl J Med. 1999;341:217–25.

    Article  CAS  PubMed  Google Scholar 

  35. Berger JS, Brown DL. Gender-age interaction in early mortality following primary angioplasty for acute myocardial infarction. Am J Cardiol. 2006;98:1140–3.

    Article  PubMed  Google Scholar 

  36. Johnson BD, Shaw LJ, Pepine CJ, Reis SE, Kelsey SF, Sopko G, et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the nih-nhlbi-sponsored women’s ischaemia syndrome evaluation (wise) study. Eur Heart J. 2006;27:1408–15.

    Article  PubMed  Google Scholar 

  37. Banks K, Lo M, Khera A. Angina in women without obstructive coronary artery disease. Curr Cardiol Rev. 2010;6:71.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Handberg EM, Eastwood JA, Eteiba W, Johnson BD, Krantz DS, Thompson DV, et al. Clinical implications of the women’s ischemia syndrome evaluation: Inter-relationships between symptoms, psychosocial factors and cardiovascular outcomes. Womens Health (Lond Engl). 2013;9:479–90.

    Article  CAS  Google Scholar 

  39. Norris CM, Spertus JA, Jensen L, Johnson J, Hegadoren KM, Ghali WA. Sex and gender discrepancies in health-related quality of life outcomes among patients with established coronary artery disease. Circ Cardiovasc Qual Outcomes. 2008;1:123–30.

    Article  PubMed  Google Scholar 

  40. Vaccarino V, Lin ZQ, Kasl SV, Mattera JA, Roumanis SA, Abramson JL, et al. Gender differences in recovery after coronary artery bypass surgery. J Am Coll Cardiol. 2003;41:307–14.

    Article  PubMed  Google Scholar 

  41. Scheuner MT, Setodji CM, Pankow JS, Blumenthal RS, Keeler E. Relation of familial patterns of coronary heart disease, stroke, and diabetes to subclinical atherosclerosis: the multi-ethnic study of atherosclerosis. Genet Med. 2008;10:879–87.

    Article  PubMed Central  PubMed  Google Scholar 

  42. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham study. Am Heart J. 1987;114:413–9.

    Article  CAS  PubMed  Google Scholar 

  43. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9.

    Article  PubMed  Google Scholar 

  44. Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. 2009;54:2366–73.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111:383–90.

    Article  CAS  PubMed  Google Scholar 

  46. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213–9.

    Article  CAS  PubMed  Google Scholar 

  47. Reuterwall C, Hallqvist J, Ahlbom A, De Faire U, Diderichsen F, Hogstedt C, et al. Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the sheep study. The sheep study group. J Intern Med. 1999;246:161–74.

    Article  CAS  PubMed  Google Scholar 

  48. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet. 2011;378:1297–305.

    Article  PubMed  Google Scholar 

  49. Steliga MA, Dresler CM. Smoking cessation: crucial to target women as well as men. Lancet. 2011;378:1278–9.

    Article  PubMed  Google Scholar 

  50. Sharma K, Gulati M. Coronary artery disease in women: a 2013 update. Glob Health. 2013;8:105–12.

    Google Scholar 

  51. Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, et al. Lifetime risks of cardiovascular disease. N Engl J Med. 2012;366:321–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  52. Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, et al. Trends in cardiovascular health metrics and associations with all-cause and cvd mortality among us adults. JAMA. 2012;307:1273–83.

    Article  CAS  PubMed  Google Scholar 

  53. Kling JM, Miller VM, Mankad R, Wilansky S, Wu Q, Zais TG, et al. Go red for women cardiovascular health-screening evaluation: the dichotomy between awareness and perception of cardiovascular risk in the community. J Womens Health (Larchmt). 2013;22:210–8.

    Article  Google Scholar 

  54. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the women’s ischemia syndrome evaluation (wise) study. Circulation. 2004;109:706–13.

    Article  PubMed  Google Scholar 

  55. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-hdl cholesterol, apolipoproteins a-i and b100, standard lipid measures, lipid ratios, and crp as risk factors for cardiovascular disease in women. JAMA. 2005;294:326–33.

    Article  CAS  PubMed  Google Scholar 

  56. Wong ND, Pio J, Valencia R, Thakal G. Distribution of c-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the national health and nutrition examination survey (nhanes) iii. Prev Cardiol. 2001;4:109–14.

    Article  PubMed  Google Scholar 

  57. Karim R, Stanczyk FZ, Hodis HN, Cushman M, Lobo RA, Hwang J, et al. Associations between markers of inflammation and physiological and pharmacological levels of circulating sex hormones in postmenopausal women. Menopause. 2010;17:785–90.

    PubMed Central  PubMed  Google Scholar 

  58. Salmon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med. 2008;121:010.

    Article  Google Scholar 

  59. Lakshman R, Forouhi NG, Sharp SJ, Luben R, Bingham SA, Khaw KT, et al. Early age at menarche associated with cardiovascular disease and mortality. J Clin Endocrinol Metab. 2009;94:4953–60.

    Article  CAS  PubMed  Google Scholar 

  60. Bairey Merz CN, Johnson BD, Sharaf BL, Bittner V, Berga SL, Braunstein GD, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the nhlbi-sponsored wise study. J Am Coll Cardiol. 2003;41:413–9.

    Article  PubMed  CAS  Google Scholar 

  61. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation. 2011;57:1404–23.

    Google Scholar 

  62. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (champs): population-based retrospective cohort study. Lancet. 2005;366:1797–803.

    Article  PubMed  Google Scholar 

  63. Han SH, Bae JH, Holmes Jr DR, Lennon RJ, Eeckhout E, Barsness GW, et al. Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis. Eur Heart J. 2008;29:1359–69.

    Article  PubMed  Google Scholar 

  64. Reis SE, Holubkov R, Conrad Smith AJ, Kelsey SF, Sharaf BL, Reichek N, et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the nhlbi wise study. Am Heart J. 2001;141:735–41.

    Article  CAS  PubMed  Google Scholar 

  65. Kothawade K, Bairey Merz CN. Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management. Curr Probl Cardiol. 2011;36:291–318.

    Article  PubMed Central  PubMed  Google Scholar 

  66. Bairey Merz CN, Pepine CJ. Syndrome x and microvascular coronary dysfunction. Circulation. 2011;124:1477–80.

    Article  PubMed  Google Scholar 

  67. von Mering GO, Arant CB, Wessel TR, McGorray SP, Bairey Merz CN, Sharaf BL, et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the national heart, lung, and blood institute-sponsored women’s ischemia syndrome evaluation (wise). Circulation. 2004;109:722–5.

    Article  Google Scholar 

  68. Houghton JL, Smith VE, Strogatz DS, Henches NL, Breisblatt WM, Carr AA. Effect of african-american race and hypertensive left ventricular hypertrophy on coronary vascular reactivity and endothelial function. Hypertension. 1997;29:706–14.

    Article  CAS  PubMed  Google Scholar 

  69. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes Jr DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101:948–54.

    Article  CAS  PubMed  Google Scholar 

  70. Madhok V, Fahey T. Cardiovascular risk estimation: important but may be inaccurate. BMJ. 2006;332(7555):1422.

  71. Kones R. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther. 2011;5:325–80.

    Article  PubMed Central  PubMed  Google Scholar 

  72. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the score project. Eur Heart J. 2003;24:987–1003.

    Article  CAS  PubMed  Google Scholar 

  73. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007;335(7611):136.

  74. NCEP. Third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) final report. Circulation. 2002;106:3143.

    Google Scholar 

  75. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. JAMA. 2007;297:611–9.

    Article  CAS  PubMed  Google Scholar 

  76. Wenger NK. The Reynolds risk score: improved accuracy for cardiovascular risk prediction in women? Nat Clin Pract Cardiovasc Med. 2007;4:366–7.

    Article  PubMed  Google Scholar 

  77. Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al. 2013 acc/aha guideline on the assessment of cardiovascular risk: a report of the american college of cardiology/american heart association task force on practice guidelines. Circulation. 2014;129:S49–73.

    Article  PubMed  Google Scholar 

  78. Gulati M, Noel Bairey Merz C. New cholesterol guidelines and primary prevention in women. Trends Cardiovasc Med. 2014;25:84–94.

    Article  PubMed  Google Scholar 

  79. Ridker PM, Cook NR. Statins: New american guidelines for prevention of cardiovascular disease. Lancet. 2013;382:1762–5.

    Article  PubMed  Google Scholar 

  80. Cook NR, Ridker PM. Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the women’s health study. JAMA Intern Med. 2014;174:1964–71.

    Article  PubMed  Google Scholar 

  81. Canto JG, Rogers WJ, Goldberg RJ, Peterson ED, Wenger NK, Vaccarino V, et al. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA. 2012;307:813–22.

    PubMed Central  CAS  PubMed  Google Scholar 

  82. Reynolds HR, Srichai MB, Iqbal SN, Slater JN, Mancini GBJ, Feit F, et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation. 2011;124:1414–25.

    Article  PubMed Central  PubMed  Google Scholar 

  83. Abdelmoneim SS, Bernier M, Dhoble A, Moir S, Hagen ME, Ness SAC, et al. Assessment of myocardial perfusion during adenosine stress using real time three-dimensional and two-dimensional myocardial contrast echocardiography: comparison with single-photon emission computed tomography. Echocardiography. 2010;27:421–9.

    Article  PubMed  Google Scholar 

  84. Tweet MS, Hayes SN, Pitta SR, Simari RD, Lerman A, Lennon RJ, et al. Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation. 2012;126:579.

    Article  PubMed  Google Scholar 

  85. Yip A, Saw J. Spontaneous coronary artery dissection-a review. Cardiovasc Diagn Ther. 2015;5:37–48.

    PubMed Central  PubMed  Google Scholar 

  86. Mieres JH, Gulati M, Bairey Merz N, Berman DS, Gerber TC, Hayes SN, et al. Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the american heart association. Circulation. 2014;130:350–79.

    Article  PubMed  Google Scholar 

  87. Gulati M, Pandey DK, Arnsdorf MF, Lauderdale DS, Thisted RA, Wicklund RH, et al. Exercise capacity and the risk of death in women: the st james women take heart project. Circulation. 2003;108:1554–9.

    Article  PubMed  Google Scholar 

  88. Bourque JM, Holland BH, Watson DD, Beller GA. Achieving an exercise workload of≥ 10 metabolic equivalents predicts a very low risk of inducible ischemia: does myocardial perfusion imaging have a role? J Am Coll Cardiol. 2009;54:538–45.

    Article  PubMed Central  PubMed  Google Scholar 

  89. Kohli P, Gulati M. Exercise stress testing in women: going back to the basics. Circulation. 2010;122:2570–80.

    Article  PubMed  Google Scholar 

  90. Hlatky MA, Pryor DB, Harrell Jr FE, Califf RM, Mark DB, Rosati RA. Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. Am J Med. 1984;77:64–71.

    Article  CAS  PubMed  Google Scholar 

  91. Alexander KP, Shaw LJ, Shaw LK, Delong ER, Mark DB, Peterson ED. Value of exercise treadmill testing in women. J Am Coll Cardiol. 1998;32:1657–64.

    Article  CAS  PubMed  Google Scholar 

  92. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical-diagnosis of coronary-artery disease. N Engl J Med. 1979;300:1350–8.

    Article  CAS  PubMed  Google Scholar 

  93. Marwick TH, Nemec JJ, Pashkow FJ, Stewart WJ, Salcedo EE. Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol. 1992;19:74–81.

    Article  CAS  PubMed  Google Scholar 

  94. Williams MJ, Marwick TH, O’Gorman D, Foale RA. Comparison of exercise echocardiography with an exercise score to diagnose coronary artery disease in women. Am J Cardiol. 1994;74:435–8.

    Article  CAS  PubMed  Google Scholar 

  95. Kim C, Kwok YS, Heagerty P, Redberg R. Pharmacologic stress testing for coronary disease diagnosis: a meta-analysis. Am Heart J. 2001;142:934–44.

    Article  CAS  PubMed  Google Scholar 

  96. Roger VL, Pellikka PA, Bell MR, Chow CW, Bailey KR, Seward JB. Sex and test verification bias. Impact on the diagnostic value of exercise echocardiography. Circulation. 1997;95:405–10.

    Article  CAS  PubMed  Google Scholar 

  97. Arruda-Olson AM, Juracan EM, Mahoney DW, McCully RB, Roger VL, Pellikka PA. Prognostic value of exercise echocardiography in 5,798 patients: Is there a gender difference? J Am Coll Cardiol. 2002;39:625–31.

    Article  PubMed  Google Scholar 

  98. McCully RB, Roger VL, Mahoney DW, Karon BL, Oh JK, Miller Jr FA, et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. J Am Coll Cardiol. 1998;31:144–9.

    Article  CAS  PubMed  Google Scholar 

  99. Gerber TC, Gibbons RJ. Weighing the risks and benefits of cardiac imaging with ionizing radiation. JACC Cardiovasc Imaging. 2010;3:528–35.

    Article  PubMed  Google Scholar 

  100. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the international multicenter confirm (coronary ct angiography evaluation for clinical outcomes: an international multicenter registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol. 2011;58:849–60.

    Article  PubMed  Google Scholar 

  101. Hoffmann U, Bamberg F, Chae CU, Nichols JH, Rogers IS, Seneviratne SK, et al. Coronary computed tomography angiography for early triage of patients with acute chest pain: The romicat (rule out myocardial infarction using computer assisted tomography) trial. J Am Coll Cardiol. 2009;53:1642–50.

    Article  PubMed Central  PubMed  Google Scholar 

  102. Schlett CL, Banerji D, Siegel E, Bamberg F, Lehman SJ, Ferencik M, et al. Prognostic value of ct angiography for major adverse cardiac events in patients with acute chest pain from the emergency department: 2-year outcomes of the romicat trial. JACC Cardiovasc Imaging. 2011;4:481–91.

    Article  PubMed Central  PubMed  Google Scholar 

  103. Devries S, Wolfkiel C, Fusman B, Bakdash H, Ahmed A, Levy P, et al. Influence of age and gender on the presence of coronary calcium detected by ultrafast computed tomography. J Am Coll Cardiol. 1995;25:76–82.

    Article  CAS  PubMed  Google Scholar 

  104. Budoff MJ, Shokooh S, Shavelle RM, Kim HT, French WJ. Electron beam tomography and angiography: sex differences. Am Heart J. 2002;143:877–82.

    Article  PubMed  Google Scholar 

  105. Douglas PS, Hoffmann U, Patel MR, Mark DB, Al-Khalidi HR, Cavanaugh B, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015;372(14):1291–300.

  106. Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J. 2012;33:2771–2782b.

    Article  PubMed Central  PubMed  Google Scholar 

  107. Wei J, Mehta PK, Johnson BD, Samuels B, Kar S, Anderson RD, et al. Safety of coronary reactivity testing in women with no obstructive coronary artery disease. JACC Cardiovasc Interv. 2012;5:646–53.

    Article  PubMed Central  PubMed  Google Scholar 

  108. Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, Handberg EM, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the national heart, lung and blood institute wise (women’s ischemia syndrome evaluation) study. J Am Coll Cardiol. 2010;55:2825–32.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  109. Rossi R, Nuzzo A, Origliani G, Modena MG. Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol. 2008;51:997–1002.

    Article  PubMed  Google Scholar 

  110. Bonetti PO, Pumper GM, Higano ST, Holmes Jr DR, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004;44:2137–41.

    Article  PubMed  Google Scholar 

  111. Matsuzawa Y, Sugiyama S, Sugamura K, Nozaki T, Ohba K, Konishi M, et al. Digital assessment of endothelial function and ischemic heart disease in women. J Am Coll Cardiol. 2010;55:1688–96.

    Article  PubMed  Google Scholar 

  112. Sedlak TL, Lee M, Izadnegahdar M, Merz CNB, Gao M, Humphries KH. Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease. Am Heart J. 2013;166:38–44.

    Article  PubMed  Google Scholar 

  113. Lerman A, Sopko G. Women and cardiovascular heart disease: clinical implications from the women’s ischemia syndrome evaluation (wise) study. Are we smarter? J Am Coll Cardiol. 2006;47:S59–62.

    Article  PubMed  Google Scholar 

  114. Hasdai D, Cannan CR, Mathew V, Holmes Jr DR, Lerman A. Evaluation of patients with minimally obstructive coronary artery disease and angina. Int J Cardiol. 1996;53:203–8.

    Article  CAS  PubMed  Google Scholar 

  115. Amsterdam EA, Wenger NK, Brindis RG, Casey Jr DE, Ganiats TG, Holmes Jr DR, et al. 2014 aha/acc guideline for the management of patients with non-st-elevation acute coronary syndromes: a report of the american college of cardiology/american heart association task force on practice guidelines. J Am Coll Cardiol. 2014;64:e139–228.

    Article  PubMed  Google Scholar 

  116. Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Trynosky K, Diercks DB, et al. Gender disparities in the diagnosis and treatment of non-st-segment elevation acute coronary syndromes: large-scale observations from the crusade (can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the american college of cardiology/american heart association guidelines) national quality improvement initiative. J Am Coll Cardiol. 2005;45:832–7.

    Article  PubMed  Google Scholar 

  117. Gehrie ER, Reynolds HR, Chen AY, Neelon BH, Roe MT, Gibler WB, et al. Characterization and outcomes of women and men with non-st-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the acc/aha guidelines (crusade) quality improvement initiative. Am Heart J. 2009;158:688–94.

    Article  PubMed  Google Scholar 

  118. Daly C, Clemens F, Lopez Sendon JL, Tavazzi L, Boersma E, Danchin N, et al. Gender differences in the management and clinical outcome of stable angina. Circulation. 2006;113:490–8.

    Article  PubMed  Google Scholar 

  119. Dey S, Flather MD, Devlin G, Brieger D, Gurfinkel EP, Steg PG, et al. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the global registry of acute coronary events. Heart. 2009;95:20–6.

    Article  CAS  PubMed  Google Scholar 

  120. Steg PG, Greenlaw N, Tardif JC, Tendera M, Ford I, Kaab S, et al. Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective clarify registry. Eur Heart J. 2012;33:2831–40.

    Article  PubMed Central  PubMed  Google Scholar 

  121. Collaborative overview of randomised trials of antiplatelet therapy--i: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet trialists’ collaboration. BMJ. 1994;308:81–106.

  122. Chan AT, Manson JE, Feskanich D, Stampfer MJ, Colditz GA, Fuchs CS. Long-term aspirin use and mortality in women. Arch Intern Med. 2007;167:562–72.

    Article  PubMed  Google Scholar 

  123. Becker DM, Segal J, Vaidya D, Yanek LR, Herrera-Galeano JE, Bray PF, et al. Sex differences in platelet reactivity and response to low-dose aspirin therapy. JAMA. 2006;295:1420–7.

    Article  CAS  PubMed  Google Scholar 

  124. Ridker PM, Hennekens CH, Tofler GH, Lipinska I, Buring JE. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women. J Cardiovasc Risk. 1996;3:209–12.

    Article  CAS  PubMed  Google Scholar 

  125. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto Jr AM, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med. 2008;359:2195–207.

    Article  CAS  PubMed  Google Scholar 

  126. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7–22.

  127. Lewis SJ, Sacks FM, Mitchell JS, East C, Glasser S, Kell S, et al. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (care) trial. J Am Coll Cardiol. 1998;32:140–6.

    Article  CAS  PubMed  Google Scholar 

  128. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495–504.

    Article  CAS  PubMed  Google Scholar 

  129. O’Donoghue M, Boden WE, Braunwald E, Cannon CP, Clayton TC, de Winter RJ, et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-st-segment elevation myocardial infarction: a meta-analysis. JAMA. 2008;300:71–80.

    Article  PubMed  Google Scholar 

  130. Lavie CJ, Milani RV. Effects of cardiac rehabilitation and exercise training on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in women. Am J Cardiol. 1995;75:340–3.

    Article  CAS  PubMed  Google Scholar 

  131. Balady GJ, Ades PA, Bittner VA, Franklin BA, Gordon NF, Thomas RJ, et al. Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond a presidential advisory from the american heart association. Circulation. 2011;124:2951–60.

    Article  PubMed  Google Scholar 

  132. Lerman A, Burnett Jr JC, Higano ST, McKinley LJ, Holmes Jr DR. Long-term l-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation. 1998;97:2123–8.

    Article  CAS  PubMed  Google Scholar 

  133. Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014;35:1101–11.

    Article  PubMed Central  PubMed  Google Scholar 

  134. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA. 2002;288:321–33.

    Article  CAS  PubMed  Google Scholar 

  135. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women’s health initiative randomized controlled trial. JAMA. 2004;291:1701–12.

    Article  CAS  PubMed  Google Scholar 

  136. Harman SM, Black DM, Naftolin F, Brinton EA, Budoff MJ, Cedars MI, et al. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med. 2014;161:249–60.

    Article  PubMed  Google Scholar 

  137. Schierbeck LL, Rejnmark L, Tofteng CL, Stilgren L, Eiken P, Mosekilde L, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 2012;345:e6409.

  138. Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, et al. Conjugated equine estrogens and coronary heart disease - the women’s health initiative. Arch Intern Med. 2006;166:357–65.

    Article  CAS  PubMed  Google Scholar 

  139. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen/progestin replacement study (hers) research group. JAMA. 1998;280:605–13.

    Article  CAS  PubMed  Google Scholar 

  140. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II). JAMA. 2002;288:49–57.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Mayo Clinic, Rochester, MN, USA

    LaPrincess C. Brewer, Anna Svatikova & Sharon L. Mulvagh

  2. Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    LaPrincess C. Brewer, Anna Svatikova & Sharon L. Mulvagh

Authors
  1. LaPrincess C. Brewer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Svatikova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sharon L. Mulvagh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sharon L. Mulvagh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brewer, L.C., Svatikova, A. & Mulvagh, S.L. The Challenges of Prevention, Diagnosis and Treatment of Ischemic Heart Disease in Women. Cardiovasc Drugs Ther 29, 355–368 (2015). https://doi.org/10.1007/s10557-015-6607-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-015-6607-4

Keywords

Search

Navigation